Navigation
Pages
Welcome to ScanBalt Business
Today's Portrait Highlights
Medixine

Medixine combine expertise in health care and modern web and mobile technology to provide safe and easy to use patient centric solutions. Our solutions enable smooth collaboration between health care providers, patients and family members. We provide tools for connecting different data sources and optimizing care processes. With our help, our partners and customers can enhance the quality of care and achieve cost savings. Our solution Medixine Suite provides comprehensive communication, monitoring and collaboration tools for all parties involved in the care process. It’s based on a powerful and versatile core that can be easily customized and extended with a set of product modules.
Visit WebsiteInnoCore Pharmaceuticals

InnoCore Pharmaceuticals is specialized in the development of long acting and minimally invasive injectable drug delivery products for the treatment of chronic diseases. At InnoCore, we serve the pharmaceutical and medical device industry by developing and manufacturing innovative drug delivery systems that enhance their products. Our approach centres around our proprietary SynBiosys family of bioresorbable polymers. The SynBiosys platform allows the development of numerous different configurations resulting in the most versatile polymeric drug delivery systems today.
Visit WebsiteTampere Life Science Center

Tampere has a combination of multi-disciplinary, technological, bio-medical and medical expertise in education, research, healthcare and business sectors. In recent years, the health, wellness and biotechnology sector in the Tampere region has been the fastest growing in Finland and received the largest number of private investments in business development. The region’s wellness and health technology cluster provides some 30,000 jobs.For a presentation of the Tampere Life Science Center please follow the link below. For a presentation of BioMedTech, please see: http://biomeditech.fi/home.php
Visit Website
country-158013_640



Subscribe to newsletter